Novavax’s Protein COVID-19 Vaccine Now Available in Europe

Novavax’s Protein COVID-19 Vaccine Now Available in Europe

Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]

Moderna, Novavax Developing Combined Single-Dose COVID-19 and Influenza Vaccine

Moderna, Novavax Developing Combined Single-Dose COVID-19 and Influenza Vaccine

American pharmaceutical and biotechnology company Moderna, Inc., which partnered with the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) to develop an mRNA COVID-19 vaccine being distributed in the United States under an Emergency Use Authorization (EUA) announced that it is developing a combined single-dose booster vaccine for COVID-19 and seasonal influenza.1 In a […]